PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES AS JAK-INHIBITORS
A compound having the structure:or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, wherein A, A', A", R0, R, R1, R2, X, R4, and R5, are as defined in the description, for therapeutic use, wherein whe...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
08.11.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A compound having the structure:or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, wherein A, A', A", R0, R, R1, R2, X, R4, and R5, are as defined in the description, for therapeutic use, wherein where the compound, or the pharmaceutically acceptable salt thereof, or the pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, is administered orally. |
---|---|
Bibliography: | Application Number: HK20190100512 |